Influence of the severity of obstructive sleep apnea on nocturnal heart rate indices and its association with hypertension;Tıkayıcı uyku apnesi ciddiyetinin gece kalp hızı indeksleri üzerine etkisi ve hipertansiyon ile ilişkisi

Anadolu Kardiyoloji Dergisi

Volumn 11, Issue 6, 2011, Pages 509-514

  Özeke, Özcan ^a   Güngör, Mutlu ^a   Hzel, Serap Bilen ^a   Aydin, Dilek ^a   Ertürk, Özcan ^a   Çelenk, Mehmet Kutlu ^a   Dinçer, Hazim ^a   Iliçin, Gürler ^a   Özgen, Fuat ^a   Özer, Can ^a  

^a BAYINDIR HOSPITAL   (Turkey)

Author keywords

Hypertension; Nocturnal heart rate; Sleep apnea; Sympathetic nervous system activation

Indexed keywords

ADRENERGIC TRANSMISSION; ADULT; APNEA HYPOPNEA INDEX; BLOOD PRESSURE MEASUREMENT; CIRCADIAN RHYTHM; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DISEASE ASSOCIATION; DISEASE SEVERITY; FEMALE; HEART RATE VARIABILITY; HEMODYNAMIC MONITORING; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; POLYSOMNOGRAPHY; REVIEW; SLEEP APNEA SYNDROME; SYSTOLIC BLOOD PRESSURE;

EID: 80051955633     PISSN: 13028723     EISSN: None     Source Type: Journal    
DOI: 10.5152/akd.2011.135     Document Type: Review

References (42)

1. Turgut Çelen Y, Peker Y. Cardiovascular consequences of sleep apnea: I- Epidemiology. Anadolu Kardiyol Derg 2010; 10: 75-80.
2. Somers VK, White DP, Amin R, Abraham WT, Costa F, Culebras A, et al. Sleep apnea and cardiovascular disease: an American Heart Association/American College of Cardiology Foundation Scientific Statement from the American Heart Association Council for High Blood Pressure Research Professional Education Committee, Council on Clinical Cardiology, Stroke Council, and Council on Cardiovascular Nursing. J Am Coll Cardiol 2008; 52: 686-717.
3. Turgut Çelen Y, Peker Y. Cardiovascular consequences of sleep apnea: II-Cardiovascular mechanisms. Anadolu Kardiyol Derg 2010; 10: 168-175.
4. Dursunoǧlu D, Dursunoǧlu N. Cardiovascular diseases in obstructive sleep apnea. Tuberk Toraks 2006; 54: 382-396.
5. Fletcher EC. Effect of episodic hypoxia on sympathetic activity and blood pressure. Respir Physiol 2000; 119: 189-197.
6. Leung RS. Sleep-disordered breathing: autonomic mechanisms and arrhythmias. Prog Cardiovasc Dis 2009; 51: 324-338.
7. Koehler U, Becker HF, Grimm W, Heitmann J, Peter JH, Schäfer H. Relations among hypoxemia, sleep stage, and bradyarrhythmia during obstructive sleep apnea. Am Heart J 2000; 139: 14214-8.
8. Aytemir K, Deniz A, Yavuz B, Uǧur Demir A, Şahiner L, Çiftçi Ö, et al. Increased myocardial vulnerability and autonomic nervous system imbalance in obstructive sleep apnea syndrome. Respir Med 2007; 101: 1277-1282.
9. Pinsky MR. Sleeping with the enemy: the heart in obstructive sleep apnea. Chest 2002; 121: 1022-104.
10. Shepard JW Jr. Cardiopulmonary consequences of obstructive sleep apnea. Mayo Clin Proc 1990; 65: 1250-1259.
11. Wolf J, Lewicka J, Narkiewicz K. Obstructive sleep apnea: an update on mechanisms and cardiovascular consequences. Nutr Metab Cardiovasc Dis 2007; 17: 233-240.
12. Zwillich CW. Sleep apnea and autonomic function. Thorax 1998; 53: S20-S24.
13. Somers VK, Dyken ME, Clary MP, Abboud FM. Sympathetic neural mechanisms in obstructive sleep apnea. J Clin Invest 1995; 96: 1897-1904.
14. Somers VK, Mark AL, Zavala DC, Abboud FM. Contrasting effects of hypoxia and hypercapnia on ventilation and sympathetic activity in humans J Appl Physiol 1989; 67: 2101-2106.
15. Somers VK, Mark AL, Abboud FM. Potentiation of sympathetic nerve responses to hypoxia in borderline hypertensive subjects. Hypertension 1988; 11: 608-612.
16. Somers VK, Dyken ME, Mark AL. Parasympathetic hyperresponsiveness and bradyarrhythmias during apnea in hypertension. Clin Auton Res 1992; 2: 171-176.
17. Gonçalves SC, Martinez D, Gus M, de Abreu-Silva EO, Bertoluci C, Dutra I, et al. Obstructive sleep apnea and resistant hypertension: a case-control study. Chest 2007; 132: 1858-1862.
18. Narkiewicz K, Somers VK. The sympathetic nervous system and obstructive sleep apnea: implications for hypertension. J Hypertens 1997; 15: 1613-1619.
19. Narkiewicz K, Somers VK. Obstructive sleep apnea as a cause of neurogenic hypertension. Curr Hypertens Rep 1999; 1: 268-273.
20. Palatini P and Julius S. Heart rate and the cardiovascular risk. J Hypertens 1997; 15: 3-17.
21. Palatini P, Julius S. Association of tachycardia with morbidity and mortality: pathophysiological considerations. J Hum Hypertens 1997; 11(Suppl 1): 19-27.
22. Kannel WB, Kannel C, Paffenbarger RS Jr, Cupples LA. Heart rate and cardiovascular mortality: the Framingham Study. Am Heart J 1987; 113: 1489-1494.
23. Gillman MW, Kannel WB, Belanger A, D'Agostino RB. Influence of heart rate on mortality among persons with hypertension: the Framingham Study. Am Heart J 1993; 125: 1148-1154.
24. Benetos A, Rudnichi A, Thomas F, Safar M, Guize L. Influence of heart rate on mortality in a French population: role of age, gender, and blood pressure. Hypertension 1999; 33: 44-52.
25. Greenland P, Daviglus ML, Dyer AR, Liu K, Huang CF, Goldberger JJ, et al. Resting heart rate is a risk factor for cardiovascular and noncardiovascular mortality: the Chicago Heart Association Detection Project in Industry. Am J Epidemiol 1999; 149: 853-862.
26. Narkiewicz K, Montano N, Cogliati C, van de Borne PJ, Dyken ME, Somers VK. Altered cardiovascular variability in obstructive sleep apnea. Circulation 1998; 98: 1071-1077.
27. Roche F, Gaspoz JM, Court-Fortune I, Minini P, Pichot V, Duverney D, et al. Screening of obstructive sleep apnea syndrome by heart rate variability analysis. Circulation 1999; 100: 1411-1415.
28. Bonsignore MR, Romano S, Marrone O, Chiodi M, Bonsignore G. Different heart rate patterns in obstructive apneas during NREM sleep. Sleep 1997; 20: 1167-1174.
29. Kawano Y, Tamura A, Watanabe T, Kadota J. Influence of the severity of obstructive sleep apnea on heart rate. J Cardiol 2010; 56; 27-34.
30. Sumi K, Chin K, Takahashi K, Nakamura T, Matsumoto H, Niimi A, et al. Effect of nCPAP therapy on heart rate in patients with obstructive sleep apnoea-hypopnoea. QJM 2006; 99: 545-553.
31. Gouveris H, Selivanova O, Bausmer U, Goepel B, Mann W. Firstnight-effect on polysomnographic respiratory sleep parameters in patients with sleep-disordered breathing and upper airway pathology. Eur Arch Otorhinolaryngol 2010; 267: 1449-1453.
32. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL, et al. Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension 2003; 42: 1206-1252.
33. Sleep-related breathing disorders in adults: recommendations for syndrome definition and measurement techniques in clinical research. The Report of an American Academy of Sleep Medicine Task Force. Sleep 1999; 22: 667-689.
34. American Academy of Sleep Medicine. International Classification of Sleep Disorders. In: Diagnostic and Coding Manual. Westchester, Ill: American Academy of Sleep Medicine; 2005.
35. Ye L, Pien GW, Weaver TE. Gender differences in the clinical manifestation of obstructive sleep apnea. Sleep Med 2009; 10: 1075-1084.
36. Dancey DR, Hanly PJ, Soong C, Lee B, Shepard J Jr, Hoffstein V. Gender differences in sleep apnea: the role of neck circumference. Chest 2003; 123: 1544-1550.
37. Bradley TD, Tkacova R, Hall MJ, Ando S, Floras JS. Augmented sympathetic neural response to simulated obstructive apnoea in human heart failure. Clin Sci (Lond) 2003; 104: 231-238.
38. Morgan BJ, Denahan T, Ebert TJ. Neurocirculatory consequences of negative intrathoracic pressure vs. asphyxia during voluntary apnea. J Appl Physiol 1993; 74: 2969-2975.
39. Carlson JT, Hedner J, Elam M, Ejnell H, Sellgren J, Wallin BG. Augmented resting sympathetic activity in awake patients with obstructive sleep apnea. Chest 1993; 103: 1763-1768.
40. Narkiewicz K, van de Borne PJ, Montano N, Dyken ME, Phillips BG, Somers VK. Contribution of tonic chemoreflex activation to sympathetic activity and blood pressure in patients with obstructive sleep apnea. Circulation 1998; 97: 943-945.
41. Kraiczi H, Hedner J, Peker Y, Grote L. Comparison of atenolol, amlodipine, enalapril, hydrochlorothiazide, and losartan for antihypertensive treatment in patients with obstructive sleep apnea Am J Respir Crit Care Med 2000; 161: 1423-1428.
42. Brooks D, Horner RL, Kozar LF, Render-Teixeira CL, Phillipson EA. Obstructive sleep apnea as a cause of systemic hypertension. Evidence from a canine model. J Clin Invest 1997; 99: 106-109.